Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health

López, María Isabel; Cocohoba, Jennifer; Cohen, Stéphanie; Trainor, Nikole; Levy, Montica M.; Dong, Betty J.

doi:10.1016/j.japh.2019.06.021

Cited by 44 publications

(36 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In recent years, standalone pharmacy-based PrEP delivery programs have been successfully implemented in select parts of the U.S. (e.g., Seattle, San Francisco, Miami, Denver, St. Louis, Jackson, and Omaha) [5,[19][20][21][22][23][24].…”

Section: Introductionmentioning

confidence: 99%

Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives

et al. 2021

View full text Add to dashboard Cite

As countries scale up pre-exposure prophylaxis (PrEP) for HIV prevention, diverse PrEP delivery models are needed to expand access to populations at HIV risk that are unwilling or unable to access clinic-based PrEP care. To identify factors that may influence implementation of retail pharmacy-based PrEP delivery in Kenya, we conducted in-depth interviews with 40 pharmacy clients, 16 pharmacy providers, 16 PrEP clients, and 10 PrEP providers from two provinces. Most participants expressed strong support for expanding PrEP to retail pharmacies, though conditioned their acceptance on assurances that care would be private, respectful, safe, and affordable. Participant-reported determinants of feasibility centered primarily on ensuring that the intervention is compatible with retail pharmacy operations (e.g., staffing levels, documentation requirements). Future research is needed to develop and test tailored packages of implementation strategies that are most effective at integrating PrEP delivery into routine pharmacy practice in Kenya and other high HIV prevalence settings.

show abstract

Section: Introductionmentioning

confidence: 99%

Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives

et al. 2021

View full text Add to dashboard Cite

show abstract

“…16,17 In several states, innovative pharmacist-driven PrEP programs are available demonstrating the commitment of some pharmacists to make PrEP easily available. [18][19][20][21] Nearly all of these community pharmacies' PrEP programs are made possible under a formal collaborative practice agreement or a Collaborative Drug Therapy Agreement (CDTA), which requires a medical provider-pharmacist partnership. Arrangements under the CTDA process are not necessarily easily implemented and as such limit the extent to which these types of practices may otherwise flourish.…”

mentioning

confidence: 99%

Attitudes about community pharmacy access to HIV prevention medications in California

Koester¹,

Saberi²,

Fuller³

et al. 2020

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Increasing access to human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) is a high priority for the Ending the HIV Epidemic Initiative. Expanding access to PrEP and PEP through a variety of health care settings, including community pharmacies, may increase access in communities most in need. California is the first state to allow community pharmacists to furnish PrEP and PEP directly to consumers. Our objective was to assess attitudes among key stakeholders about a California policy to allow community pharmacists to furnish HIV PrEP and PEP. Methods: We conducted a qualitative case study with key pharmacy stakeholders. Semistructured phone interviews were audio-recorded and transcribed verbatim. We generated analytical memos for each interview and working with these analytical memos, we conducted a constant comparison across cases to identify commonalities and differences. Results: We launched the study in October 2018 and interviewed pharmacists (n ¼ 7) working in a variety of settings, including retail-, clinic-, and community-based pharmacies. We also interviewed medical providers (n ¼ 2) working in high-volume PrEP clinics and sought input from representatives of large retail chain pharmacies (n ¼ 2). Overall, pharmacists and medical provider informants shared similar opinions about the central benefits as well as the key challenges related to pharmacist-delivered PrEP and PEP services. Benefits included: community pharmacists are widely accessible, PrEP and PEP protocols are similar to other preventative medications, policy may lead to efficiencies in the health care workforce, and community pharmacists are authorities on medication adherence. Challenges included: implementation issues may limit pharmacist involvement, and missed opportunities to diagnose and treat other health conditions. Conclusion: This study characterizes the types of benefits and challenges that can be expected when PrEP and PEP prescribing privileges are extended to community pharmacists. This information may be useful to policymakers and other stakeholders considering legislation to permit direct prescription of PrEP and PEP by pharmacists.

show abstract

“…[36][37][38][39] Recently, 2 published models in Seattle, WA, and San Francisco (SF), CA, have demonstrated that pharmacists' initiation of PrEP in the community pharmacy setting can be successful. 40,41 The Seattle, WA, site uses a collaborative drug therapy agreement and has received financial reimbursement for initiating PrEP in more than 700 patients. The SF model operates under a collaborative practice agreement with the SF Department of Public Health to provide PrEP and PEP and was instrumental in the passage of SB159.…”

Section: Lessons Learned From Existing Community Pharmacy Models Of Pmentioning

confidence: 99%

Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!

López¹,

Grant²,

Dong³

2020

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health

Cited by 44 publications

References 9 publications

Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives

Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives

Attitudes about community pharmacy access to HIV prevention medications in California

Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!

Contact Info

Product

Resources

About